Fig. 2. In vitro sealing properties of the MeTro sealant.

Slides:



Advertisements
Similar presentations
Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.
Advertisements

Fig. 7. Gradient of adipocyte size and FAI around the human coronaries in the presence or absence of coronary atherosclerosis. Gradient of adipocyte size.
Fig. 1. IL-6 is associated with resistance to EGFR TKIs and is induced by stress hormones. IL-6 is associated with resistance to EGFR TKIs and is induced.
Fig. 6. dAST directly from clinical samples using dPCR and dLAMP for quantification. dAST directly from clinical samples using dPCR and dLAMP for quantification.
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
In vivo function of MeTro sealants using rat incision model of lungs
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 4. Ex vivo and in vivo function of the MeTro sealant using rat incision model of arteries. Ex vivo and in vivo function of the MeTro sealant using.
Fig. 1. The effect of dietary micronutrient deficiency on the configuration of a defined human gut microbiota established in gnotobiotic mice. The effect.
Fig. 1 SDPS induces deficits in rat spatial memory that are reversed by imipramine. SDPS induces deficits in rat spatial memory that are reversed by imipramine.
Fig. 2. dAST using dPCR is robust to the presence of high concentrations of commensal bacteria due to the specificity of NA amplification. dAST using dPCR.
Fig. 2. In vitro profiling of tEV markers on cell line–derived EVs.
Fig. 4. Biomechanical properties of treated tibiae.
Fig. 5. Prophylactic treatment with GS-5734 reduces SARS-CoV disease.
Fig. 1 Crohn’s disease association within the LRRK2 locus.
Fig. 2 Maraba treatment results in complete responses in the window of opportunity setting. Maraba treatment results in complete responses in the window.
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
MRSA virulence proteins cause LMC death and diminished CLV function
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro
Increased ADMA in pregnancy is associated with SGA birth outcomes
Fig. 3. Wisper controls CF behavior and survival.
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 6. A circadian rhythm in keratinocyte wound healing and a diurnal variation in human burn healing outcome. A circadian rhythm in keratinocyte wound.
Fig. 4. MATE1 transcription in RCC.
Fig. 6 Malaria and l-arginine induce changes in the expression of inflammatory and angiogenic mediators in placental tissue by reverse transcription PCR.
Fig. 6 ROC curves of mCCNA1 and mVIM assayed on esophageal balloon samplings of the distal esophagus. ROC curves of mCCNA1 and mVIM assayed on esophageal.
Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.
Fig. 3 Fbln4E57K/E57K mice develop large artery stiffness and systolic hypertension. Fbln4E57K/E57K mice develop large artery stiffness and systolic hypertension.
Fig. 6. Apoptotic MSCs exert in vivo immunosuppression in a TH2-type inflammation model in the absence of cytotoxic cells. Apoptotic MSCs exert in vivo.
Fig. 4. Expression of HGF in liver ECs cooperates with NOX4 inhibition to enhance engraftment of regenerative hepatocytes. Expression of HGF in liver ECs.
Fig. 4. Actin polymerization rhythms are required for circadian regulation of adhesion and wound-healing efficacy by fibroblasts. Actin polymerization.
Persistence of CAR4 cells is reduced after sustained TCR engagement
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Fig. 1. mGlu7 expression is reduced in RTT autopsy samples.
Fig. 2. Pathways differentially regulated in patients with early Lyme disease and STARI. Pathways differentially regulated in patients with early Lyme.
Fig. 2 Whisker deprivation accelerates and enhances behavioral recovery after right S1FP photothrombosis. Whisker deprivation accelerates and enhances.
Fig. 2 Paralog-selective inhibitors of GSK3α and GSK3β were designed and characterized. Paralog-selective inhibitors of GSK3α and GSK3β were designed and.
Fig. 1. Map showing the study catchment area in the East of England.
Fig. 3. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and CREB. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and.
Fig. 5 Local gel scaffold for T cell memory response.
Fig. 7 Improvement of clinical score and axon pathology by nasal IL-4 treatment during chronic EAE. Improvement of clinical score and axon pathology by.
Fig. 4. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model of ALS. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model.
Fig. 4 Effect of LRRK2 mutations on protein kinase activity and GTPase activity. Effect of LRRK2 mutations on protein kinase activity and GTPase activity.
Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.
Fig. 3 Tetrode trials and behavioral study in rats.
PAAND is driven by local inflammasome activation and IL-1β production
Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.
Fig. 6 Anticancer effects in PyMT-MMTV syngeneic and MDA-MB-231 xenograft-bearing mice. Anticancer effects in PyMT-MMTV syngeneic and MDA-MB-231 xenograft-bearing.
Fig. 4 Analysis of ISO response in vitro in neonatal cardiomyocytes.
Fig. 6. CXM correlates with age and growth velocity.
Fig. 4. Local application of FR provides prolonged protection against Gq-dependent airway constriction in normal and OVA-sensitized mice in vivo. Local.
Fig. 2. Cellular response to FolamiRs in vitro.
Fig. 1. Specificity of FolamiR uptake in cancer cells in culture.
Fig. 7. Scale-up of AAV vector–mediated liver gene transfer of secretable GAA to nonhuman primates. Scale-up of AAV vector–mediated liver gene transfer.
CSF1 secretion by melanoma cells is induced by CTL-derived cytokines
Fig. 4. Clearance of 12-mer-1 from a nonhuman primate model.
Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital.
Fig. 1. Iontophoretic devices used for the delivery of cytotoxic agents to solid tumors. Iontophoretic devices used for the delivery of cytotoxic agents.
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 2 Mechanical and antibacterial properties of AAD.
Fig. 4 Compressive stress-strain curves and specific strength of compressed GCs. Compressive stress-strain curves and specific strength of compressed GCs.
Fig. 7. Nanowarming maintains biomechanical properties of porcine carotid arteries. Nanowarming maintains biomechanical properties of porcine carotid arteries.
Fig. 2. In vitro sealing properties of the MeTro sealant.
In vivo function of MeTro sealants using rat incision model of lungs
Ex vivo application and adhesion properties of GelCORE adhesives
Presentation transcript:

Fig. 2. In vitro sealing properties of the MeTro sealant. In vitro sealing properties of the MeTro sealant. (A) Standard lap shear test to determine the shear strength of MeTro sealants (n ≥ 4) with different formulations and several commercially available sealants: Evicel (n = 5), Coseal (n = 3), and Progel (n = 4). (i) Schematic of the modified standard test method for shear test (ASTM F2255-05), (ii) representative strain-stress curves for lap shear tests, and (iii) average shear strength of MeTro sealants produced with varying MeTro concentrations and degree of methacryloyl substitution, and commercially available sealants including Evicel, Coseal, and Progel. (B) Standard burst pressure test to evaluate the burst pressure of the MeTro sealant (n ≥ 4) with different formulations [except 5% Metro (n = 2)] and several commercially available sealants: Evicel (n = 4), Coseal (n = 3), and Progel (n = 5). (i) Schematic of the modified standard test method for the burst pressure (ASTM F2392-04), (ii) representative strain-stress curves for burst pressure test, and (iii) average burst pressure of the MeTro sealants with variable MeTro concentrations and degree of methacryloyl substitution, and commercially available sealants. (C) Standard wound closure using porcine skin as the biological substrate to test the adhesion strength of the MeTro sealant (n ≥ 4) with different formulations and commercially available sealants: Evicel (n = 5), Coseal (n = 3), and Progel (n = 3). (i) Schematic of the modified standard test method for adhesion strength (ASTM F2458-05), (ii) representative strain-stress curves for wound closure test, and (iii) average adhesive strength of MeTro sealants produced with variable MeTro concentrations and degree of methacryloyl substitution, and their comparison with commercially available sealants. Data are means ± SD. P values were determined by one-way ANOVA followed by Tukey’s multiple comparisons test (*P < 0.05, **P < 0.01, ****P < 0.0001). Nasim Annabi et al., Sci Transl Med 2017;9:eaai7466 Published by AAAS